Natural Products in Clinical Trials

Natural Products in Clinical Trials

Volume: 2

Natural compounds continue to play a key role in drug development. Many clinically approved drugs are either unmodified natural products or their semi-synthetic derivatives. This book series presents ...
[view complete introduction]

US $
30

*(Excluding Mailing and Handling)



Fluorine-containing Drugs and Drug Candidates Derived from Natural Products

Pp. 123-150 (28)

Chunlin Zhuang, Yuelin Wu, Wannian Zhang and Zhenyuan Miao

Abstract

The incorporation of covalent fluorine has been widely used as an effective strategy in medicinal chemistry for drug discovery. The introduction of fluorine into a molecule can significantly influence conformation, lipophilicity, pKa, metabolism, and pharmacokinetic properties. In 1955, the first fluorinated drug fludrocortisone has been approved in the market for the treatment of the adrenogenital syndrome, postural hypotension, and adrenal insufficiency. Since then, 218 small-molecule drugs with at least one fluorine atom have been launched by U.S. FDA by the end of 2018. Therefore, this chapter is expected to summarize the fluorine-containing natural products in clinical development to the medicinal chemistry community.

Keywords:

Antiproliferative, Antiviral, Anti-inflammatory, Clinical Development, Drug Discovery, Fluorinated Drug, Medicinal Chemistry, Natural Product, Nucleosides, Small-molecule, Steroids.

Affiliation:

School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China.